MIRA INFORM REPORT

 

 

Report Date :

02.05.2012

 

IDENTIFICATION DETAILS

 

Name :

SEI CHENG BIOTECHNOLOGY CO., LTD.

 

 

Registered Office :

1F., No.255, Sec.1, Yuan Shui Road, Cheng Shing Li, Yuanlin, Chung Hua Hsien

 

 

Country :

Taiwan

 

 

Date of Incorporation :

27.07.2009

 

 

Com. Reg. No.:

24450223

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Trading of chemicals

 

 

No. of Employees :

Not Available

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

Payment Behaviour :

Regular

Litigation :

---

 


 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Taiwan

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


Contact Points

 

Company Name:

Sei Cheng Biotechnology Co., Ltd.

Supplied Name:

Sei Cheng Biotechnology

Trading Address:

1F., No.255, Sec.1, Yuan Shui Road, Cheng Shing Li, Yuanlin, Chung Hua Hsien, Taiwan

Supplied Address:

No. 255, Sec 1 Yuan Shui Yuanlin Changhua County Taiwan

Telephone Number:

+886-4-8365121

Fax Number:

+886-4-8365125

Notes:

The exact subject’s name and address are as above mentioned.

 

 

Credit Summary

 

Credit Opinion:

Business connections are permissible.

 

 

Company Identification Details

 

Registered Name:

Sei Cheng Biotechnology Co., Ltd.

Registered Address:

1F., No.255, Sec.1, Yuan Shui Road, Cheng Shing Li, Yuanlin, Chung Hua Hsien, Taiwan

Date of Foundation:

2009-7-27

Registration Number:

24450223

Registry:

Ministry of Economic Affairs Central Office

Registered Capital:

NTD 30,000,000 (USD 990,000)

(As of 2012.04, 1 NTD = 0.033 USD)

Paid-up Capital:

NTD 30,000,000 (USD 990,000)

Legal Representatives:

Jinxiong Weng

Legal Form:

Joint Stock Company

Principal Activities:

Trading of chemicals

Staff:

N/A

Listed at Stock Exchange:

No

Date of Last Annual Return:

2011-11-2

Notes:

Subject declined to introduce its staff number.

 

 

History

 

Subject was incorporated on 2009-7-27 with registered number 24450223 as Joint Stock Company in Taiwan.

Change of Name

Former Chinese Name

协成生化科技股份有限公司

Current Chinese Name

欣宏生化科技股份有限公司

 

 

Shareholders

 

Name

Subscription Shares

Jinxiong Weng

100,000            

 

Ruihong Weng

 

300,000

 

Ruilong Weng

300,000

Jinyuan Weng

200,000

 

The information above is that of subject’s major shareholders.

 

 

Subsidiaries & Branches

 

Subject did not register any subsidiaries or branches, from other source we can not obtain the relevant information, either.

 

 


Personnel Information

 

Core Management

Directors

1

Name

Jinxiong Weng

Position

Chairman

2

Name

Ruihong Weng

Position

Director

3

Name

Ruilong Weng

Position

Director

4

Name

Jinyuan Weng

Position

Supervisor

 

 

Operation Information

 

Offices & Factories

 

Headquarters

Add

1F., No.255, Sec.1, Yuan Shui Road, Cheng Shing Li, Yuanlin, Chung Hua Hsien, Taiwan

Operations

l         The registered activities of subject:

Business Code

Details

F102170

Wholesaling of food

F107200

Wholesaling of chemical raw material

F107990

Wholesaling of other chemicals

F121010

Wholesaling of food additive

F199990

Other wholesaling

F203010

Retailing of food and beverage

F207200 

Retailing of chemical raw material

F207990

Retailing of other chemicals

F299990

Other retailing

F401010

International trade

ZZ99999

Besides licensed business, all other business items those are not banned or restricted.

l         The subject has a proportion of 50% for Import.

l         The subject is mainly engaged in trading of various chemicals.

l         Subject’s products include chemical raw material, food additive, etc.

l         Subject has both domestic and foreign markets.

l         Subject exports according to orders.

l         The subject has a proportion of 50% for export.

Import and export right:

Import right

Yes

Export right

Yes

 

 

Settlements

 

Purchase

Domestic Purchase

Product

Payment Terms

Proportion

Chemicals

COD, CBD, etc.

100%

Foreign Purchase

Product

Payment Terms

Proportion

Chemicals

COD, CBD, etc.

100%

Sales

Domestic Markets

Product

Sales Terms

Proportion

Chemicals

COD, CBD, etc.

100%

 

Export

Product

Sales Terms

Proportion

Chemicals

COD, CBD, etc.

100%

 

 

Financial Information

 

Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.

Subject’s relevant staff declined to disclose its financials citing the grounds of company’s confidentiality; from other source we can not obtain the relevant information, either.

 

 

Public Record

 

Mortgage

No chattel mortgage record of subject has been found within the recent 3 months.

Lawsuit

Up to date of reporting, no existing or latent litigation of the subject has been found.

Notes:

The woman who answered the telephone declined to introduce her name.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.68

UK Pound

1

Rs.85.12

Euro

1

Rs.69.38

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.